Lerige
Food supplement declared in France, declaration No 2018-7-289
Lerige is a food supplement declared in France. Status: retiré du marché le 12 March 2021. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- DRAPEAU MICRONUTRITION FRANCE
- Status
- Retiré du marché le 12 March 2021
- Form
- Gélule
- Daily dose
- 2 à 5 gélules
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Artères et cholestérol
Declaration 289721, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Contains red yeast rice. Monacolins must remain below 3 mg per daily portion, with mandatory warnings on the label. The monacolin content is not declared in Compl'Alim.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/860).
- Information
Retiré du marché le 12 March 2021, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Monascus purpureus Went | Graine | Autre extrait sec | 1,575 mg |
Additives
E470b, E551, E141
Other ingredients
gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé chez les personnes sensibles aux statines et en cas de thérapie avec des médicaments hypolipidémiant. Demander l'avis de votre médecin.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.